Cargando…
Revealing biomarkers associated with PARP inhibitors based on genetic interactions in cancer genome
Poly (ADPribose) polymerase inhibitors (PARPis) are clinically approved drugs designed according to the concept of synthetic lethality (SL) interaction. It is crucial to expand the scale of patients who can benefit from PARPis, and overcome drug resistance associated with it. Genetic interactions (G...
Autores principales: | Dong, Qi, Liu, Mingyue, Chen, Bo, Zhao, Zhangxiang, Chen, Tingting, Wang, Chengyu, Zhuang, Shuping, Li, Yawei, Wang, Yuquan, Ai, Liqiang, Liu, Yaoyao, Liang, Haihai, Qi, Lishuang, Gu, Yunyan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Research Network of Computational and Structural Biotechnology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8379270/ https://www.ncbi.nlm.nih.gov/pubmed/34471490 http://dx.doi.org/10.1016/j.csbj.2021.08.007 |
Ejemplares similares
-
An individualized transcriptional signature to predict the epithelial-mesenchymal transition based on relative expression ordering
por: Chen, Tingting, et al.
Publicado: (2020) -
Genetic Interaction-Based Biomarkers Identification for Drug Resistance and Sensitivity in Cancer Cells
por: Han, Yue, et al.
Publicado: (2019) -
Individualized lncRNA differential expression profile reveals heterogeneity of breast cancer
por: Zhao, Zhangxiang, et al.
Publicado: (2021) -
RHPCG: a database of the Regulation of the Hippo Pathway in Cancer Genome
por: Wang, Chengyu, et al.
Publicado: (2019) -
Discovering a qualitative transcriptional signature of homologous recombination defectiveness for prostate cancer
por: Li, Yawei, et al.
Publicado: (2021)